Focused All Cap Equity

Objective

Palisade’s Focused All Cap Equity portfolios seek to achieve attractive long-term performance over full market cycles, primarily through fundamental, bottom-up research. We apply risk analysis tools, measuring sector and style factors that can limit inadvertent exposures and may enhance risk-adjusted returns.

Philosophy

We believe a focused portfolio best applies our experience, diligence, and judgment to more accurately and consistently predict long-term outcomes and potentially generate attractive returns. Through fundamental research and company meetings, we seek to narrow the universe down to a portfolio comprised of 20-30 compounders of shareowner value. Portfolio company management teams tend to distinguish themselves through continuous operational improvement, highly competitive corporate strategies, and disciplined/effective deployment of capital.

Benchmark

Russell 3000® Index

At-A-Glance As of September 30, 2020

Investment Experience

30+

YEARS

Typical Number of Holdings

20-30

Weighted average market cap

$352

BILLION

Maximum security weight

15%

Want to Learn More?

Investment Team


William Potter: Managing Director,
Senior Portfolio Manager


Dennison “Dan” T. Veru: Chief Investment Officer
Co-Chairman, Board of Directors

Latest Related News & Insight

Thursday, October 08, 2020
Palisade Capital Management Ranked Among Top 100 Financial Advisors by CNBC
Posted in Announcements: Palisade Capital Management is thrilled to announce that the firm has been included in CNBC’s ranking of the top 100 financial advisory firms in 2020. The “CNBC FA 100” celebrates advisory firms that top the list with regard to offering comprehensive planning and financial services that help clients navigate their financial lives. The CNBC FA 100 rankings take into consideration factors beyond assets under management and are based on a proprietary methodology developed by CNBC in partnership with data provider AccuPoint Solutions. In preparing the CNBC FA 100, data was culled from thousands of advisory firms.; Read More

Wednesday, January 20, 2021
Q4 2020 Investor Commentary
Posted in Market Commentaries: Palisade reviews a remarkably unusual year as we remember last year’s financial market extremes: anxiety in the first months of the COVID-19 pandemic (March/April), stabilization at mid-year, and sharp recovery in the final quarter of 2020 as investors cheered the regulatory approval of COVID vaccines.; Read More

Tuesday, December 15, 2020
An Expert’s View: The COVID-19 Vaccine
Posted in Webinars: Palisade Capital Management Chief Investment Officer Dan Veru and Senior Vice President of Research Dawn Brock hosted an informative evening with Dr. Kayvon Modjarrad, who leads the U.S. Army's development of a vaccine against COVID-19 and co-leads all of Walter Reed Army Institute of Research’s COVID-19 response efforts. Dr. Modjarrad provided an update on the most recent vaccine efforts and answered questions pertaining to COVID-19 vaccines. Dan and Dawn facilitated the discussion and offered their insights regarding how Palisade Capital views the evolving vaccine landscape as both an investment thesis and as part of 2021’s overall market outlook.

View more Palisade News & Insight

Institutional Investors

Traditional Strategies